Since we have identified elevations of both autoantibodies against adrenergic and muscarinic receptors in our study group, the approximate 30-fold elevation of IL-1β (Table 3) in these patients supports published data that suggest POTS is an autoimmune disorder, presumably via the persistent activation of T cells. Here, IL1B is linked to Autoimmunity.